The appointment of Xu Zhengwen as non-executive director and Xiaowang as independent non-executive director of ZGC TEC LEASING (01601) has taken effect.

21:10 30/12/2025

Zhongguancun Technology Leasing (01601) announced that the Company has recently received the approval of the qualification for Mr. Xu Zhengwen to serve as a non-executive director and Mr. Xiao Wang to serve as an independent non-executive director of the Company from the Beijing Local Financial Supervision and Administration Bureau. Accordingly, the appointment of Mr. Xu Zhengwen as a non-executive director and Mr. Xiao Wang as an independent non-executive director of the Company has taken effect, starting from December 30, 2025, until the expiration of the term of the second board of directors. Starting from December 30, 2025, Mr. Xu Zhengwen will also serve as a member of the second board of directors' audit committee. Starting from December 30, 2025, Mr. Xiao Wang will also serve as the chairman of the second board of directors' remuneration committee, a member of the audit committee, a member of the nomination committee, and a member of the risk control committee.

ZGC TEC LEASING (01601) announces that the company has recently received approval from the Beijing Local Financial Supervision Authority for the appointment of Mr. Xu Zhengwen as a non-executive director of the company and Mr. Xiao Wang as an independent non-executive director. As a result, Mr. Xu Zhengwen's appointment as a non-executive director and Mr. Xiao Wang's appointment as an independent non-executive director have taken effect from December 30, 2025 until the end of the second term of the board of directors. Starting from December 30, 2025, Mr. Xu Zhengwen will also serve as a member of the Audit Committee of the second term of the board of directors. Starting from December 30, 2025, Mr. Xiao Wang will also serve as the Chairman of the Compensation Committee, a member of the Audit Committee, a member of the Nomination Committee, and a member of the Risk Control Committee of the second term of the board of directors.

RIZHAO PORT JR(06117): Jinfeng appointed as non-executive director.

MicroPort CardioFlow-TAVR (02160): The VitaFlow series of transcatheter aortic valve and delivery systems has entered 35 countries and regions worldwide, with a cumulative implantation of nearly 1300 cases.

CHINA NEXT-GEN (03928) announced its annual performance, with a net loss of approximately 880,900 Singapore dollars, an increase of 12.34% compared to the previous year.

RIZHAO PORT JR(06117): Jinfeng appointed as non-executive director.

CHINA NEXT-GEN (03928) announced its annual performance, with a net loss of approximately 880,900 Singapore dollars, an increase of 12.34% compared to the previous year.